Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lensar Inc (NQ: LNSR )

2.990 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Lensar Inc

< Previous 1 2 Next >
LENSAR Reports Second Quarter 2023 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups
From LENSAR, Inc.
Via Business Wire
LENSAR Reports First Quarter 2023 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023
From LENSAR, Inc.
Via Business Wire
LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results
From LENSAR, Inc.
Via Business Wire
LENSAR to Present at Two Upcoming Investor Conferences
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022
From LENSAR, Inc.
Via Business Wire
LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU
From LENSAR, Inc.
Via Business Wire
First Patients Treated with LENSAR’s® ALLY™ Adaptive Cataract Treatment System
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022
From LENSAR, Inc.
Via Business Wire
LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System
From LENSAR, Inc.
Via Business Wire
LENSAR Reports First Quarter 2022 Financial Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
From LENSAR, Inc.
Via Business Wire
LENSAR to Participate in Two Upcoming Investor Conferences
From LENSAR, Inc.
Via Business Wire
LENSAR to Present at the H.C. Wainwright Virtual BioConnect Conference
From LENSAR, Inc.
Via Business Wire
LENSAR to Present at Two Upcoming Investor Conferences
From LENSAR, Inc.
Via Business Wire
LENSAR Announces Poster Presentations at the American Academy of Ophthalmology
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Third Quarter 2021 Financial Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR to Report Third Quarter 2021 Financial Results on Monday, November 8, 2021
From LENSAR, Inc.
Via Business Wire
LENSAR to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
From LENSAR, Inc.
Via Business Wire
LENSAR to Present at the H.C. Wainwright Ophthalmology Virtual Conference
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Second Quarter 2021 Financial Results and Provides Business Update
From LENSAR
Via Business Wire
LENSAR to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021
From LENSAR, Inc.
Via Business Wire
LENSAR Announces In-Person Demonstrations of Its Next Generation ALLY™ System and Multiple Data Presentations at the American Society of Cataract and Refractive Surgery (ASCRS) 2021 Annual Meeting
From LENSAR, Inc.
Via Business Wire
LENSAR to Present at the Oppenheimer MedTech, Tools, & Diagnostics Summit
From LENSAR, Inc.
Via Business Wire
LENSAR Reports First Quarter 2021 Financial Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.